Literature DB >> 25020159

The emerging role of exosomes in survivin secretion.

Salma Khan1, Heather Ferguson Bennit1, Nathan R Wall2.   

Abstract

The tumor microenvironment plays an integral part in the biology of cancer, participating in tumor initiation, progression, and response to therapy. Factors released by tumor cells themselves contribute in creating an environment mostly favorable but sometimes detrimental to the tumor. Survivin, one of the key members of the inhibitor of apoptosis (IAP) family of proteins, has been shown in the cytoplasm, mitochondria, nucleus, and most recently in the extracellular space, transported via small membrane bound vesicles called exosomes. Exosomes are secreted from hematopoietic, non-hematopoietic, tumor, and non-tumor cells, shuttling essential molecules such as proteins, RNAs, and microRNAs, all believed to be important for cell-cell and cell-extracellular communication. In this review, we discuss exosomal Survivin and its role in modifying the tumor microenvironment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25020159      PMCID: PMC4489405          DOI: 10.14670/HH-30.43

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  83 in total

Review 1.  The case for survivin as a regulator of microtubule dynamics and cell-death decisions.

Authors:  Dario C Altieri
Journal:  Curr Opin Cell Biol       Date:  2006-08-24       Impact factor: 8.382

Review 2.  Exosomes: proteomic insights and diagnostic potential.

Authors:  Richard J Simpson; Justin We Lim; Robert L Moritz; Suresh Mathivanan
Journal:  Expert Rev Proteomics       Date:  2009-06       Impact factor: 3.940

3.  Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes.

Authors:  L Zitvogel; A Regnault; A Lozier; J Wolfers; C Flament; D Tenza; P Ricciardi-Castagnoli; G Raposo; S Amigorena
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

4.  Survivin is released from cancer cells via exosomes.

Authors:  Salma Khan; Jessica M S Jutzy; Jonathan R Aspe; Dalmor W McGregor; Jonathan W Neidigh; Nathan R Wall
Journal:  Apoptosis       Date:  2011-01       Impact factor: 4.677

5.  Senescence-associated exosome release from human prostate cancer cells.

Authors:  Brian D Lehmann; Matthew S Paine; Adam M Brooks; James A McCubrey; Randall H Renegar; Rong Wang; David M Terrian
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

6.  The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression.

Authors:  Chloe Milsom; Joanne Yu; Linda May; Brian Meehan; Nathalie Magnus; Khalid Al-Nedawi; Jim Luyendyk; Jefferey Weitz; Petr Klement; George Broze; Nigel Mackman; Janusz Rak
Journal:  Thromb Res       Date:  2007       Impact factor: 3.944

7.  The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness.

Authors:  A Ginestra; M D La Placa; F Saladino; D Cassarà; H Nagase; M L Vittorelli
Journal:  Anticancer Res       Date:  1998 Sep-Oct       Impact factor: 2.480

Review 8.  Exosome: from internal vesicle of the multivesicular body to intercellular signaling device.

Authors:  K Denzer; M J Kleijmeer; H F Heijnen; W Stoorvogel; H J Geuze
Journal:  J Cell Sci       Date:  2000-10       Impact factor: 5.285

Review 9.  The application of exosomes as a nanoscale cancer vaccine.

Authors:  Aaron Tan; Hugo De La Peña; Alexander M Seifalian
Journal:  Int J Nanomedicine       Date:  2010-11-10

10.  Enhancement of Gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the Survivin-T34A mutant.

Authors:  Jonathan R Aspe; Carlos J Diaz Osterman; Jessica M S Jutzy; Simone Deshields; Sonia Whang; Nathan R Wall
Journal:  J Extracell Vesicles       Date:  2014-02-17
View more
  15 in total

1.  Endoplasmic Reticulum-resident Heat Shock Protein 90 (HSP90) Isoform Glucose-regulated Protein 94 (GRP94) Regulates Cell Polarity and Cancer Cell Migration by Affecting Intracellular Transport.

Authors:  Suman Ghosh; Heather E Shinogle; Nadezhda A Galeva; Rick T Dobrowsky; Brian S J Blagg
Journal:  J Biol Chem       Date:  2016-02-12       Impact factor: 5.157

2.  The Presence of Survivin on B Cells from Myasthenia Gravis Patients and the Potential of an Antibody to a Modified Survivin Peptide to Alleviate Weakness in an Animal Model.

Authors:  Xiangyang Zhang; Michael Ciesielski; Robert A Fenstermaker; Henry J Kaminski; Linda L Kusner
Journal:  J Immunol       Date:  2020-08-24       Impact factor: 5.422

3.  Proteomic Profiling of Serum-Derived Exosomes from Ethnically Diverse Prostate Cancer Patients.

Authors:  David Turay; Salma Khan; Carlos J Diaz Osterman; Matthew P Curtis; Balreet Khaira; Jonathan W Neidigh; Saied Mirshahidi; Carlos A Casiano; Nathan R Wall
Journal:  Cancer Invest       Date:  2015-11-04       Impact factor: 2.176

4.  Association of Epidermal Growth Factor 61A>G, Survivin -31G>C, and EFNA1 -1732G>A Polymorphisms with Susceptibility to Colorectal Cancer.

Authors:  Fatemeh Asadian; Mohammadamin Ghadyani; Mohamad Hossein Antikchi; Seyed Alireza Dastgheib; Hossein Neamatzadeh; Elnaz Sheikhpour; Sahel Khajehnoori; Seyed Sajjad Tabei
Journal:  J Gastrointest Cancer       Date:  2020-11-12

5.  Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial.

Authors:  Adrian Levitsky; Malin C Erlandsson; Ronald F van Vollenhoven; Maria I Bokarewa
Journal:  BMC Med       Date:  2015-09-30       Impact factor: 8.775

6.  Evaluation of a New Survivin ELISA and UBC® Rapid for the Detection of Bladder Cancer in Urine.

Authors:  Jan Gleichenhagen; Christian Arndt; Swaantje Casjens; Carmen Meinig; Holger Gerullis; Irina Raiko; Thomas Brüning; Thorsten Ecke; Georg Johnen
Journal:  Int J Mol Sci       Date:  2018-01-11       Impact factor: 5.923

Review 7.  Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy.

Authors:  James R W McMullen; Matthew Selleck; Nathan R Wall; Maheswari Senthil
Journal:  Oncotarget       Date:  2017-06-27

Review 8.  Exosomes as Naturally Occurring Vehicles for Delivery of Biopharmaceuticals: Insights from Drug Delivery to Clinical Perspectives.

Authors:  Arun Butreddy; Nagavendra Kommineni; Narendar Dudhipala
Journal:  Nanomaterials (Basel)       Date:  2021-06-03       Impact factor: 5.076

Review 9.  Survivin: a unique target for tumor therapy.

Authors:  Himani Garg; Prerna Suri; Jagdish C Gupta; G P Talwar; Shweta Dubey
Journal:  Cancer Cell Int       Date:  2016-06-23       Impact factor: 5.722

Review 10.  The Rules and Functions of Nucleocytoplasmic Shuttling Proteins.

Authors:  Xuekun Fu; Chao Liang; Fangfei Li; Luyao Wang; Xiaoqiu Wu; Aiping Lu; Guozhi Xiao; Ge Zhang
Journal:  Int J Mol Sci       Date:  2018-05-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.